Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index; 7 of the 9 sources its claims cite were checked for support.

Senolytics improve physical function and increase lifespan in old age

Open access

Abstract

Physical function declines in old age, portending disability, increased health expenditures, and mortality. Cellular senescence, leading to tissue dysfunction, may contribute to these consequences of aging, but whether senescence can directly drive age-related pathology and be therapeutically targeted is still unclear. Here we demonstrate that transplanting relatively small numbers of senescent cells into young mice is sufficient to cause persistent physical dysfunction, as well as to spread cellular senescence to host tissues. Transplanting even fewer senescent cells had the same effect in older recipients and was accompanied by reduced survival, indicating the potency of senescent cells in shortening health- and lifespan. The senolytic cocktail, dasatinib plus quercetin, which causes selective elimination of senescent cells, decreased the number of naturally occurring senescent cells and their secretion of frailty-related proinflammatory cytokines in explants of human adipose tissue. Moreover, intermittent oral administration of senolytics to both senescent cell-transplanted young mice and naturally aged mice alleviated physical dysfunction and increased post-treatment survival by 36% while reducing mortality hazard to 65%. Our study provides proof-of-concept evidence that senescent cells can cause physical dysfunction and decreased survival even in young mice, while senolytics can enhance remaining health- and lifespan in old mice.

Overview

CoChat Summary

TL;DR

Transplanting small numbers of senescent cells into mice caused persistent physical dysfunction and, in older recipients, reduced survival; intermittent senolytics (dasatinib plus quercetin, D+Q) alleviated dysfunction and extended remaining lifespan in old mice. D+Q also reduced senescent-cell markers and SASP cytokine secretion in human adipose tissue explants.

Key findings

  • In young 6-month-old mice, transplanting 10^6 senescent preadipocytes lowered maximal walking speed, hanging endurance, and grip strength by 1 month versus controls; 0.5 × 10^6 senescent cells was sufficient to impair grip strength and walking speed, while 0.2 × 10^6 had no detectable effects. The authors estimate this corresponds to 0.01–0.03% of body cells or 0.28% locally.
  • In 17-month-old mice, 0.5 × 10^6 senescent cells caused lower walking speed, hanging endurance, and grip strength, and was associated with a 5.2-fold higher risk of death over the following year (mortality hazard ratio, P = 0.006). High-fat diet exacerbated senescent-cell-induced dysfunction.
  • In human omental adipose tissue explants from 8 obese subjects (BMI 45.5 ± 9.1 kg/m²; age 45.7 ± 8.3 years), D+Q (1 μM dasatinib + 20 μM quercetin) for 48 h reduced TAF+, p16INK4A-high, and SA-βgal+ cells, increased apoptosis, and lowered secretion of IL-6, IL-8, MCP-1, PAI-1, and GM-CSF.
  • In aged mice, intermittent D+Q starting at 24–27 months increased median post-treatment lifespan by 36% and reduced mortality hazard to 64.9% (P = 0.01), while physical function in the last 2 months of life was not lower than vehicle-treated mice.

Methods

  • Mouse transplantation studies used senescent or control preadipocytes, mainly induced by 10 Gy radiation (>85% senescent), injected intraperitoneally into young (6-month), older (17-month), high-fat-diet, autologous, and SCID-beige models; physical function was assessed by RotaRod, grip strength, hanging test, treadmill, and daily activity/food intake.
  • Human omental adipose tissue explants from obese subjects were treated ex vivo with D+Q or vehicle for 48 h, then assessed by SA-βgal, TAF, p16INK4A immunostaining, apoptosis markers, and multiplex cytokine analysis of conditioned medium.
  • Aged-mouse studies treated 20-month-old mice with D+Q or vehicle intermittently for 4 months, and 24–27-month-old mice every 2 weeks for 3 consecutive days; survival was analyzed with Cox proportional hazard models, with INK-ATTAC/AP20187 used as a genetic clearance comparison.

Limitations

  • The paper states that efficacy of senolytics in tissues from older humans needs to be compared with explants from obese subjects, and that preclinical toxicity studies and optimized regimens are required before trials in relatively healthy humans; it also notes dasatinib can have serious side effects such as pulmonary edema after 8–48 months of daily administration, though mouse side effects may differ from humans.
  • The paper states that no statistical power analysis was used; sample sizes were based on previous experiments.
  • Evident from the text: the causal transplantation and lifespan evidence is in mice, while the human data are ex vivo adipose explants rather than clinical outcomes; the study also focuses mainly on preadipocytes/adipose tissue and selected senolytic agents.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41591-018-0092-9

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Image 1
From the PDF
Image 2
From the PDF
Image 3
From the PDF
Image 4
From the PDF
Image 5
From the PDF
Image 6
From the PDF

Verification

Claims the paper makes

3 Valid · 2 Not valid · 1 Not checked · 124 Own results and interpretations

78 more claims

Create a free account to see all 130 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 20
  • It may state two separate claims as one. 32

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

55 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 66 references

Cited by

See all 2,330

Metadata

Authors
Xu, M., Pirtskhalava, T., Farr, J. N., Weigand, B. M., Palmer, A. K., Weivoda, M. M., Inman, C. L., Ogrodnik, M. B., Hachfeld, C. M., Fraser, D. G., Onken, J. L., Johnson, K. O., Verzosa, G. C., Langhi, L. G. P., Weigl, M., Giorgadze, N., LeBrasseur, N. K., Miller, J. D., Jurk, D., Singh, R. J., Allison, D. B., Ejima, K., Hubbard, G. B., Ikeno, Y., Cubro, H., Garovic, V. D., Hou, X., Weroha, S. J., Robbins, P. D., Niedernhofer, L. J., Khosla, S., Tchkonia, T., & Kirkland, J. L.
Affiliations
  • Mayo Clinic (US)
  • Newcastle University (GB)
  • University of Alabama at Birmingham (US)
  • The University of Texas at San Antonio Health Science Center (US)
  • Scripps Research Institute (US)
Corresponding author
  • Xu, Ming
  • Kirkland, James L.
Venue
Nature Medicine
Published
2018-07-09
Volume
24
Issue
8
Pages
1246-1256
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W2860743873
Cited by
2,287
References
66
Citations by year
2026: 275 · 2025: 310 · 2024: 327 · 2023: 306 · 2022: 304 · 2021: 275 · 2020: 257 · 2019: 182 · 2018: 47
FWCI
130.81
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
  • National Institutes of Health (UL1TR002377)
  • National Institute on Aging (P01AG043376, F30AG046061, R01AG048792, R01AG044376, P01AG004875, R01AG013925, R21AG049182, P30AG013319, R37AG013925, U19AG056278, P30AG050886)
  • National Heart, Lung, and Blood Institute (R01HL141819)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK050456)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (K01AR070281, K01AR070241)
  • National Center for Advancing Translational Sciences
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
Keywords
senolytics, cellular senescence, physical function, lifespan extension, aging, dasatinib, quercetin, frailty, inflammatory cytokines, adipose tissue, mortality, healthspan
MeSH terms
Dasatinib, Adipose Tissue, Animals, Longevity, Mice, Inbred C57BL, Quercetin, Stress, Physiological, Survival Analysis, Cytokines, Cellular Senescence, Cell Transplantation, Inflammation Mediators, Diet, High-Fat

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-11-08, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-08 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Senolytics improve physical function and increase lifespan in old age. https://app.cochat.ai/papers/10.1038/s41591-018-0092-9
The paper
Xu, M., Pirtskhalava, T., Farr, J. N., Weigand, B. M., Palmer, A. K., Weivoda, M. M., Inman, C. L., Ogrodnik, M. B., Hachfeld, C. M., Fraser, D. G., Onken, J. L., Johnson, K. O., Verzosa, G. C., Langhi, L. G. P., Weigl, M., Giorgadze, N., LeBrasseur, N. K., Miller, J. D., Jurk, D., . . . Kirkland, J. L. (2018). Senolytics improve physical function and increase lifespan in old age. Nature Medicine. https://doi.org/10.1038/s41591-018-0092-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.